- Home
- ICUI vs GENI Comparison
ICUI vs GENI Comparison
Compare ICUI & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- GENI
- Stock Information
- Founded
- ICUI 1984
- GENI 2016
- Country
- ICUI United States
- GENI United Kingdom
- Employees
- ICUI N/A
- GENI N/A
- Industry
- ICUI Medical/Dental Instruments
- GENI Services-Misc. Amusement & Recreation
- Sector
- ICUI Health Care
- GENI Consumer Discretionary
- Exchange
- ICUI Nasdaq
- GENI Nasdaq
- Market Cap
- ICUI 3.0B
- GENI 2.4B
- IPO Year
- ICUI 1992
- GENI N/A
- Fundamental
- Price
- ICUI $128.18
- GENI $12.87
- Analyst Decision
- ICUI Buy
- GENI Strong Buy
- Analyst Count
- ICUI 6
- GENI 15
- Target Price
- ICUI $185.00
- GENI $13.60
- AVG Volume (30 Days)
- ICUI 371.2K
- GENI 6.6M
- Earning Date
- ICUI 08-07-2025
- GENI 08-06-2025
- Dividend Yield
- ICUI N/A
- GENI N/A
- EPS Growth
- ICUI N/A
- GENI N/A
- EPS
- ICUI N/A
- GENI N/A
- Revenue
- ICUI $2,372,504,000.00
- GENI $558,439,000.00
- Revenue This Year
- ICUI N/A
- GENI $23.90
- Revenue Next Year
- ICUI N/A
- GENI $16.01
- P/E Ratio
- ICUI N/A
- GENI N/A
- Revenue Growth
- ICUI 2.96
- GENI 25.76
- 52 Week Low
- ICUI $107.00
- GENI $6.72
- 52 Week High
- ICUI $196.26
- GENI $13.10
- Technical
- Relative Strength Index (RSI)
- ICUI 55.51
- GENI 66.49
- Support Level
- ICUI $120.95
- GENI $12.31
- Resistance Level
- ICUI $125.02
- GENI $13.10
- Average True Range (ATR)
- ICUI 5.30
- GENI 0.52
- MACD
- ICUI 1.12
- GENI -0.01
- Stochastic Oscillator
- ICUI 82.93
- GENI 87.63
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.